A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease
PHASE2
Crohn's disease (CD) is a long-lasting condition causing inflammation that ...
Status
Terminated
Location
Digestive Health Specialists of the Southeast /ID# 239599
A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154
PHASE2
Polymyalgia rheumatica (PMR) is an inflammatory disease causing shoulder, h...
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)
PHASE2
Rheumatoid Arthritis (RA) is an inflammatory disease of the joints causing ...